The MOSAIC platform was developed within the “ECBiG – European Centre for Bioinformatics and Genomics – MOSAIC” (POIR.04.02.00-00-D017/20) project carried out between 2021 and 2023 by a consortium consisting of:
The initiative was co-financed by the European Regional Development Fund under the Intelligent Development Operational Programme 2014-2020.
The ECBiG-MOSAIC project seeks to overcome this challenge by establishing a platform that harnesses the power of artificial intelligence. Our goal is to facilitate innovative research, integrating multidimensional biomedical and clinical data to unlock new knowledge. This knowledge, in turn, will empower widely accessible, personalized preventive, diagnostic, and therapeutic practices.
Our overarching research objective extends to pioneering interceptive medicine in Poland. Unlike traditional approaches, interceptive medicine focuses on identifying early molecular changes, enabling preventive actions before a pathological state develops.
The MOSAIC platform will not only benefit research centers, healthcare units, and biotech companies but will extend its impact to society at large. By supporting the prevention, diagnosis, and
therapy of civilization-related diseases, MOSAIC opens new avenues for understanding risk factors, identifying high-risk groups, and creating modern methods for early diagnosis and prevention.
Join us in this groundbreaking endeavor as we bridge the gap between scientific achievement and practical healthcare solutions, shaping the future of medicine for generations to come.